Juliet K. Simpson

Statistics

Publications

Citations

1.1K

H-Index

Active since

2015

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Royal Brompton Hospital

Imperial College London

NIHR Royal Brompton Cardiovascular Biomedical Research Unit

University College London

Juliet K. Simpson is an author at GlaxoSmithKline (United Kingdom) specializing in interstitial lung disease, fibrosis, and pulmonary fibrosis progression.

Publications per year

2015–2020

Publications

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

Gísli Jenkins, Juliet K. Simpson, Gauri Saini et al. · The Lancet Respiratory Medicine · 2015 · 324 citations · Full text

Medicine, Clinical Sciences, Pathology +17

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study

Toby M. Maher, Eunice Oballa, Juliet K. Simpson et al. · The Lancet Respiratory Medicine · 2017 · 275 citations · Full text

Medicine, Molecular Medicine, Pathology +16

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis

Pauline T. Lukey, Stephen A. Harrison, Shuying Yang et al. · European Respiratory Journal · 2019 · 145 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

Louise Organ, Anne-Marie R. Duggan, Eunice Oballa et al. · Respiratory Research · 2019 · 142 citations · Full text

Medicine, Clinical Sciences, Pathology +17

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

Toby M. Maher, Juliet K. Simpson, Joanna C. Porter et al. · Respiratory Research · 2020 · 81 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 8